A truncated cytoplasmic topoisomerase IIα in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34

International Journal of Cancer

Volumn 85, Issue 4, 2000, Pages 534-539

  Mirski, Shelagh E L ^a   Sparks, Kathryn E ^a   Yu, Qiang ^a,b   Lang, Alexander J ^a   Jain, Nidhi ^a   Campling, Barbara G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ALLELE; ARTICLE; CANCER CELL CULTURE; EXON; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ANALYSIS;

3' UNTRANSLATED REGIONS; ALLELES; ANTIGENS, NEOPLASM; CARCINOMA, SMALL CELL; CLONE CELLS; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; EXONS; HUMANS; INTRONS; ISOENZYMES; LUNG NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; TUMOR CELLS, CULTURED;

EID: 0033978551     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000215)85:4<534::AID-IJC15>3.0.CO;2-X     Document Type: Article

References (23)

1. ADACHI, N., MIYAIKE, M., KATO, S., KANAMARU, R., KOYAMA, H. and KIKUCHI, A., Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain. Nucleic Acids Res., 23, 3135-3142 (1997).
2. AUSTIN, C.A. and MARSH, K.L., Eukaryotic DNA topoisomerase IIβ. BioEssays, 20, 215-226 (1998).
3. CAMPAIN, J.A., GOTTESMAN, M.M. and PASTAN, I., A novel mutant topoisomerase IIα present in VP-16-resislant human melanoma cell lines has a deletion of alanine 429. Biochemistry, 33, 11327-11332 (1994).
4. COWELL, I.G., WILLMORE, E., CHALTON, D., MAKSH, K.L., JAZRAWI, E., FISHER, L.M. and AUSTIN, C.A., Nuclear distribution of human DNA topoisomerase IIβ: a nuclear targeting signal resides in the 116-residue C-terminal tail. Exp. Cell Res., 243, 232-240 (1998).
5. CRENSHAW, D.G. and HSIEH, T., Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. II. In vivo studies. J. Biol. Chem., 268, 21335-21343 (1993).
6. DEREUDDRE, S., DELAPORTE, C. and JACQUEMIN-SABLON, A., Role of topoisomerase IIβ in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblast to topoisomerase II inhibitors. Cancer Res., 57, 4301-4308 (1997).
7. FELDHOFF, P.W., MIRSKI, S.E.L., COLE, S.P.C. and SULLIVAN, D.M.M., Altered subcellular distribution of topoisomerase IIα in a drug-resistant human small-cell lung cancer cell line. Cancer Res., 54, 756-762 (1994).
8. GRUE, P., GRASSER, A., SEHESTED, M., JENSEN, P.B., UHSE, A., STRAUB, T., NESS, W. and BOEGE, P., Essential mitotic functions of topoisomerase IIα are not adopted by topoisomerase IIβ in human H69 cells. J. Biol. Chem., 273, 33660-33666 (1998).
9. HARKER, W.G., SLADE, D.L., PARR, R.L., FELDHOFF, P.W., SULLIVAN, D.M. and HOLGUIN, M.H., Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res., 55, 1707-1716 (1995a).
10. HARKER, W.G., SLADE, D.L., PARR, R.L. and HOLGUIN, M.H., Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase IIα messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone. Cancer Res., 55, 4962-4971 (1995b).
11. JAIN, N., LAM, Y.-M., PYM, J. AND CAMPLING, B.C., Mechanisms of resistance of human small-cell lung cancer lines selected in VP-16 and cisplatin. Cancer, 77, 1797-1808 (1996).
12. KAUFMANN, S.H. AND SVINGEN, P.A., Immunoblot analysis and band depiction assays. In: Bjornsti, M.-A. and Osheroff, N. (eds.), Protocols in DNA topology and topoisomerases. Part I: DNA topology and enzymes, pp. 253-267. Humana Press, Totowa, New Jersey (1998).
13. LANG, A.J., MIRSKI, S.E.L., CUMMINGS, H.J., YU, Q., GERLACH, J.H. and COLE, S.P.C., Structural organization of the human TOP2A and TOP2B genes. Gene, 221, 255-266 (1998).
14. MIGHELL, A.J., MARKHAM, A.F. and ROBINSON, P.A., Alu sequences. FEBS Lett., 417, 1-5 (1997).
15. r 160.000 topoisomerase IIα is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Cancer Res., 55, 2129-2134 (1995).
16. MIRSKI, S.E.L. and COLE, S.P.C., Multidrug resistance in small cell lung cancer. In: Bernal, S.D. (ed.), Drug resistance in oncology, pp. 27-75. M. Dekker, New York (1997).
17. MIRSKI, S.E.L., GERLACH, J.H. and COLE, S.P.C., Sequence determinants of nuclear localization in the α and β isoforms of human topoisomerase II. Exp. Cell Res., 251, 329-339 (1999).
18. MIRSKI, S.E.L., GERLACH, J.H., CUMMINGS, H.J., ZIRNGIBL, R., GREER, P.A. and COLE, S.P.C., Bipartite nuclear localization signals in the C-terminus of human topoisomerase IIα. Exp. Cell Res., 237, 452-455 (1997).
19. SHIOZAKI, K. and YANAGIDA, M., A functional 125-kDa core polypeptide of fission yeast DNA topoisomerase II. Mol. Cell. Biol., 11, 6093-6102 (1991).
20. TSAI-PFLUGFELDER, M., LIU, L.F., LIU, A.A., TEWEY, K.M., WHANG-PENG, J., KNUTSEN, T., HUEBNER, K., CROCE, C.M. and WANG, J.C., Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Nat. Acad. Sci. (Wash.), 85, 7177-7181 (1988).
21. 1492 in the COOH-terminal region of topoisomerase IIα in human small-cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. Cancer Res., 57, 4451-4454 (1997).
22. WILLMORE, E., FRANK, A.J., PADGET, K., TILBY, M.J. and AUSTIN, C.A., Etoposide targets topoisomerase IIα and IIβ in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique. Mol. Pharmacol., 53, 78-85 (1998).
23. YU, Q., MIRSKI, S.E.L., SPARKS, K.E. and COLE, S.P.C., Two COOH-terminal truncated cytoplasmic mutant forms of topoisomerase IIα in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing. Biochemistry, 36, 5868-5877 (1997).